These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5454682)

  • 1. Unexpected sensitivity of tumor cells to cyclophosphamide in one-day-old solid Ehrlich ascites tumors.
    Urano M; Tanaka N; Shirakura I
    Gan; 1970 Aug; 61(4):353-8. PubMed ID: 5454682
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative studies of the cytostatic effect of a new N-Lost derivative "IMET 3393" and Endoxan in 3 experimental mice tumors (Ehrlich ascites carcinoma, sarcoma 180 solid, leukemia LAJ I)].
    Schnabel R; Jungstand W; Gutsche W; Grimm H; Fritsch S
    Acta Biol Med Ger; 1967; 19(4):543-58. PubMed ID: 5596676
    [No Abstract]   [Full Text] [Related]  

  • 3. [Synergistic effect of the combination of thymidine and cyclophosphamide on Ehrlich ascites tumor].
    Osswald H
    Z Krebsforsch; 1970; 74(4):376-82. PubMed ID: 4253311
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of BCG on the survival of mice following intraperitoneal administration of Ehrlich ascites tumor cells].
    Jakóbisiak M; Kossakowska AE; Zelechowska M; Kamiński M
    Med Dosw Mikrobiol; 1974; 26(3):235-40. PubMed ID: 4409404
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of subcutaneous transplants of Ehrlich carcinoma on the survival time of mice with intraperitoneal transplants of the same tumour.
    Hartveit F; Halleraker B
    J Pathol; 1971 Oct; 105(2):85-93. PubMed ID: 5135341
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the electrolyte changes in serum and ascites during cytostatic therapy of transplanted tumors].
    Asbach HW
    Arzneimittelforschung; 1968 Sep; 18(9):1180-2. PubMed ID: 5755934
    [No Abstract]   [Full Text] [Related]  

  • 7. Dynamics of antitumor resistance after cyclophosphamide injection.
    Terpinskaya TI
    Bull Exp Biol Med; 2012 Mar; 152(5):613-4. PubMed ID: 22803147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cyclophosphamide on Ehrlich ascites cells.
    Liss E; Palme G
    Antimicrob Agents Chemother (Bethesda); 1965; 5():493-6. PubMed ID: 5883464
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction between subcutaneous and intraperitoneal transplants of the Ehrlich carcinoma; the possible role of anti-tumour antibody.
    Hallerbaker B; Hartveit F
    J Pathol; 1971 Oct; 105(2):95-103. PubMed ID: 5135342
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in the electrophoretic mobility and growth pattern of Ehrlich carcinoma cells following transplantation in tumour-bearing mice.
    Halleraker B; Hartveit F
    J Pathol; 1970 Feb; 100(2):P8. PubMed ID: 5420766
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of cyclophosphamide on tumor cell sensitivity to the action of immunological effectors.
    Culo F; Marić M; Morović-Vergles J
    In Vivo; 1995; 9(5):439-46. PubMed ID: 8900921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematologic changes in rats inoculated intraperitoneally with Ehrlich ascites carcinoma.
    Dabrowska B; Janik P; Radwański Z; Dux K
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):724-9. PubMed ID: 5957994
    [No Abstract]   [Full Text] [Related]  

  • 13. [Features of Ehrlich ascites tumor metastasis].
    Kiseleva NS
    Vopr Onkol; 1971; 17(9):81-4. PubMed ID: 5138811
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of growth of Ehrlich ascites tumors in ICR-Ha Swiss mice by isocyanates.
    Moos GE; Maguire JA; Kitchlew TZ; Swyers WA; Volk PZ; Croft JR; Quigley MJ; Fries JR; Oser NA; Anderson LJ
    Cancer Res; 1971 Jul; 31(7):937-41. PubMed ID: 5560387
    [No Abstract]   [Full Text] [Related]  

  • 15. [Overadditive synergism of combinations of cyclophosphamide with thymidine, adenosine or uridine in transplantation tumors].
    Osswald H
    Arzneimittelforschung; 1972 Jul; 22(7):1184-8. PubMed ID: 4678126
    [No Abstract]   [Full Text] [Related]  

  • 16. The theta antigenicity of lymphoid organs of mice bearing the Ehrlich ascites tumor.
    Loring M; Schlesinger M
    Cancer Res; 1970 Aug; 30(8):2204-7. PubMed ID: 5466693
    [No Abstract]   [Full Text] [Related]  

  • 17. Growth of subcutaneous grafts of some clones of Ehrlich ascites tumor in mice of different strains.
    Bregula U; Slowikowska G; Dux K
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):711-6. PubMed ID: 5957992
    [No Abstract]   [Full Text] [Related]  

  • 18. The prevention of Ehrlich ascites tumor using intraperitoneal colloidal 198Au. Dose vs. size of inoculum.
    Rogoff EE; Romano R; Hahn EW
    Radiology; 1975 Jan; 114(1):225-6. PubMed ID: 1208864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On the implantation of ascites tumor cells into the peritoneum].
    Rovenskiĭ IuA
    Vopr Onkol; 1966; 12(6):70-6. PubMed ID: 4299468
    [No Abstract]   [Full Text] [Related]  

  • 20. Dynamics of growth and regression of Ehrlich ascites carcinoma transplanted intraperitoneally in rats.
    Janik P; Dabrowski M; Dux K
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):717-23. PubMed ID: 5957993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.